These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 32159961)
1. Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles. Liu S; Li R; Qian J; Sun J; Li G; Shen J; Xie Y Mol Pharm; 2020 Apr; 17(4):1415-1427. PubMed ID: 32159961 [TBL] [Abstract][Full Text] [Related]
2. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
3. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
4. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306 [TBL] [Abstract][Full Text] [Related]
5. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838 [TBL] [Abstract][Full Text] [Related]
6. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo. Wang J; Li Y; Wang L; Wang X; Tu P Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064 [TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537 [TBL] [Abstract][Full Text] [Related]
8. Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance. Qiu L; Xu J; Ahmed KS; Zhu M; Zhang Y; Long M; Chen W; Fang W; Zhang H; Chen J Acta Biomater; 2022 Mar; 140():686-699. PubMed ID: 34875359 [TBL] [Abstract][Full Text] [Related]
9. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles. Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072 [TBL] [Abstract][Full Text] [Related]
10. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance. Wang S; Yang Y; Wang Y; Chen M Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923 [TBL] [Abstract][Full Text] [Related]
11. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer. Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537 [TBL] [Abstract][Full Text] [Related]
12. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein. Jin Y; Zhang Z; Zhao T; Liu X; Jian L J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136 [TBL] [Abstract][Full Text] [Related]
13. Polyethyleneimine- -Tocopherol Hydrogen Succinate/Hyaluronic Acid-Quercetin (PEI-TOS/HA-QU) Core-Shell Micelles Delivering Paclitaxel for Combinatorial Treatment of MDR Breast Cancer. Qian J; Liu S; Yang T; Xiao Y; Sun J; Zhao J; Zhang Z; Xie Y J Biomed Nanotechnol; 2021 Mar; 17(3):382-398. PubMed ID: 33875073 [TBL] [Abstract][Full Text] [Related]
14. Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers. Hong W; Chen D; Zhang X; Zeng J; Hu H; Zhao X; Qiao M Biomaterials; 2013 Dec; 34(37):9602-14. PubMed ID: 24021757 [TBL] [Abstract][Full Text] [Related]
15. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer. Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670 [TBL] [Abstract][Full Text] [Related]
16. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin. Wang J; Ma W; Guo Q; Li Y; Hu Z; Zhu Z; Wang X; Zhao Y; Chai X; Tu P Int J Nanomedicine; 2016; 11():5851-5870. PubMed ID: 27853369 [TBL] [Abstract][Full Text] [Related]
17. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance. Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018 [TBL] [Abstract][Full Text] [Related]
18. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
19. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells. Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039 [TBL] [Abstract][Full Text] [Related]
20. Mixed micelles based on a pH-sensitive prodrug and TPGS for enhancing drug efficacy against multidrug-resistant cancer cells. Sun D; Lv X; Wang X; Yu A; Wang Y Colloids Surf B Biointerfaces; 2017 Nov; 159():419-426. PubMed ID: 28823972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]